← Back to Search
Proteomic Profiling Of The NCI-60 Cancer Cell Lines Using New High-density Reverse-phase Lysate Microarrays
S. Nishizuka, L. Charboneau, Lynn M Young, S. Major, W. Reinhold, M. Waltham, H. Kouros-Mehr, K. Bussey, J. Lee, V. Espina, P. Munson, E. Petricoin, L. Liotta, J. Weinstein
Published 2003 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Because most potential molecular markers and targets are proteins, proteomic profiling is expected to yield more direct answers to functional and pharmacological questions than does transcriptional profiling. To aid in such studies, we have developed a protocol for making reverse-phase protein lysate microarrays with larger numbers of spots than previously feasible. Our first application of these arrays was to profiling of the 60 human cancer cell lines (NCI-60) used by the National Cancer Institute to screen compounds for anticancer activity. Each glass slide microarray included 648 lysate spots representing the NCI-60 cell lines plus controls, each at 10 two-fold serial dilutions to provide a wide dynamic range. Mouse monoclonal antibodies and the catalyzed signal amplification system were used for immunoquantitation. The signal levels from the >30,000 data points for our first 52 antibodies were analyzed by using p-scan and a quantitative dose interpolation method. Clustered image maps revealed biologically interpretable patterns of protein expression. Among the principal early findings from these arrays were two promising pathological markers for distinguishing colon from ovarian adenocarcinomas. When we compared the patterns of protein expression with those we had obtained for the same genes at the mRNA level by using both cDNA and oligonucleotide arrays, a striking regularity appeared: cell-structure-related proteins almost invariably showed a high correlation between mRNA and protein levels across the NCI-60 cell lines, whereas non-cell-structure-related proteins showed poor correlation.
This paper references
S Nishizuka (2003)
'Omic' and hypothesis-driven research in the molecular pharmacology of cancer.
J. Weinstein (2002)
Development of a prostate cDNA microarray and statistical gene expression analysis package
A. J. Carlisle (2000)
K J Bussey (2003)
J. Natl. Cancer Inst
A Monks (1991)
U Scherf (2000)
J. Natl. Cancer Inst
K D Paull (1989)
Curr. Opin. Pharmacol
J N Weinstein (2002)
An Information-Intensive Approach to the Molecular Pharmacology of Cancer
J. Weinstein (1997)
Biochim. Biophys. Acta
D Barilá (1995)
Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.
A. Monks (1991)
N. & Kirsch, I. R. Cancer Res
A V Roschke
Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling.
S. Nishizuka (2003)
Systematic variation in gene expression patterns in human cancer cell lines
D. T. Ross (2000)
Proteomic profiling of the cancer microenvironment by antibody arrays
V. Knezevic (2001)
Integrated genomic and proteomic analyses of a systematically perturbed metabolic network.
T. Ideker (2001)
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front
C. Paweletz (2001)
AC Tose (1993)
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.
M. Alley (1988)
Correlation between Protein and mRNA Abundance in Yeast
S. Gygi (1999)
Mol. Cell. Biol
S P Gygi (1999)
D T Ross (2000)
Proc. Natl. Acad. Sci. USA 88
W T Lankes (1991)
Villin is a major protein of the microvillus cystoskeleton which binds both G and F actin in a calcium-dependent manner
A. Bretscher (1980)
A gene expression database for the molecular pharmacology of cancer
U. Scherf (2000)
S F Stinson (1992)
Chemosensitivity prediction by transcriptional profiling
J. E. Staunton (2001)
E Pringault (1986)
J N Weinstein (2002)
E-cadherin gene mutations in human gastric carcinoma cell lines.
T. Oda (1994)
Protein microarrays: meeting analytical challenges for clinical applications.
Lance A. Liotta (2003)
THE CANCER CELL
A. Chadli (1963)
B B Haab (2001)
A human villin cDNA clone to investigate the differentiation of intestinal and kidney cells in vivo and in culture.
E. Pringault (1986)
Transcriptional regulation of the ezrin gene during rat intestinal development and epithelial differentiation.
D. Barilà (1995)
M C Alley (1988)
J K Lee
Differential localization by in situ hybridization of distinct keratin mRNA species during intestinal epithelial cell development and differentiation.
D. Calnek (1993)
Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.
K. Paull (1989)
A J Carlisle (2000)
J. Biol. Chem
O Farrell (1975)
A comparison of selected mRNA and protein abundances in human liver
L. Anderson (1997)
High resolution two-dimensional electrophoresis of proteins.
P. O'Farrell (1975)
Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen.
S. Stinson (1992)
C P Paweletz (1981)
大房 健 (2005)
Moesin: a member of the protein 4.1-talin-ezrin family of proteins.
W. Lankes (1991)
A protein expression database for the molecular pharmacology of cancer
T. G. Myers (1997)
J. Bonner (1968)
Proc. Natl. Acad. Sci. USA 98
J E Staunton (2001)
The bioinformatics of microarray gene expression profiling.
J. Weinstein (2002)
Proc. Natl. Acad. Sci. USA 91
T Oda (1994)
This paper is referenced by
A Correction to the Perspective Titled: "Emerging Miniaturized Proteomic Technologies to Study Cell Signaling in Clinical Samples" by Taranjit S. Gujral and Gavin MacBeath
T. S. Gujral (2009)
Chapter 16 Clinical cancer proteomics
A. Alaiya (2005)
Proteomics of breast cancer
E. Petricoin (2006)
A Highly Sensitive Porous Silicon (P-Si)-Based Human Kallikrein 2 (hK2) Immunoassay Platform toward Accurate Diagnosis of Prostate Cancer
S. Lee (2015)
Reverse‐phase protein arrays for application‐orientated cancer research
U. Korf (2009)
Challenges in cancer research and multifaceted approaches for cancer biomarker quest
J. Martínková (2009)
Inorganic nanoparticles for predictive oncology of breast cancer.
M. Yezhelyev (2009)
Reverse-phase protein lysate microarrays for cell signaling analysis
Brett Spurrier (2008)
"Lineage addiction" in human cancer: lessons from integrated genomics.
L. Garraway (2005)
Computational Biology Approaches to Support Biomarker Discovery and Development
B. Li (2020)
Functional Microarray Platform with Self-Assembled Monolayers on 3C-Silicon Carbide.
Oren Cooper (2020)
Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel
I. Cortés-Ciriano (2016)
Protein microchips in biomedicine and biomarker discovery
S. Spisák (2007)
Proteomics Discovery of Disease Biomarkers
M. Ahram (2008)
Dissection of Signaling Pathways in Fourteen Breast Cancer Cell Lines Using Reverse-Phase Protein Lysate Microarray
M. Akkiprik (2006)
Surface Adjustment of Reverse Phase Protein Arrays using Positive Control Spots
E. Neeley (2012)
Alternative Mammalian Target of Rapamycin (mTOR) Signal Activation in Sorafenib-resistant Hepatocellular Carcinoma Cells Revealed by Array-based Pathway Profiling*
M. Masuda (2014)
CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set.
W. Reinhold (2012)
Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines
Tiannan Guo (2019)
Correlating gene and protein expression data using Correlated Factor Analysis
Chuen Seng Tan (2008)
An integrated analysis of molecular aberrations in NCI-60 cell lines
C. Yeang (2010)
Microarrays in Chemical Biology
A. N. Koehler (2008)
Printing of protein microarrays via a capillary‐free fluid jetting mechanism
J. Barron (2005)
Integromic analysis of the NCI-60 cancer cell lines.
J. Weinstein (2004)
Systematic investigation of global coordination among mRNA and protein in cellular society
Haiyun Wang (2009)
Impact of blocking and detection chemistries on antibody performance for reverse phase protein arrays.
Kristi L H Ambroz (2011)
Multiplex approaches in protein microarray technology
B. Kersten (2005)
Sparse Canonical Covariance Analysis for High-throughput Data
Woojoo Lee (2011)
Expression profiling of homocysteine junction enzymes in the NCI60 panel of human cancer cell lines.
W. Zhang (2005)
Utility of Reverse-Phase Protein Array for Refining Precision Oncology.
M. Masuda (2019)
Handling missing rows in multi-omics data integration: multiple imputation in multiple factor analysis framework
V. Voillet (2016)
Development of a Sol-gel-assisted Reverse-phase Microarray Platform for Simple and Rapid Detection of Prostate-specific Antigen from Serum
S. W. Lee (2018)See more